| Literature DB >> 36167962 |
A S Fouda1, M A Ismail2, M A Khaled2,3, A A El-Hossiany2,4.
Abstract
Inhibition of copper corrosion by some pyrimidinone derivatives, namely; (E)-N-(3-((1,3-dimethyl-2,4,6-trioxohexahydropyrimidin-5-yl)diazenyl)-2,5-diethoxyphenyl)benzamide (MA-975) and(E)-6-(4-((4-chlorophenyl)diazenyl)-3-methyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)-1,3 dimethylpyrimidine-2,4(1H,3H)-dione (MA-978C) in 1.0 M nitric acid (HNO3) was studied using weight loss (WL), electrochemical impedance spectroscopy (EIS), and potentiodynamic polarization (PP) measurements. The efficiency of inhibition increases as the concentration of inhibitor increases, and it also increases as the temperature increases. With the addition of the examined inhibitors, significant corrosion protection was obtained, and (MA-975) showed a very promising % IE (89.59%) at 21 × 10-6 M using the (WL) method. The polarization data revealed that these compounds act as mixed-type compounds and are adsorbed on the copper surface following Langmuir adsorption isotherm forming a protective thin film protecting the metal in the corrosive media. Scanning electron microscopy (SEM) and Energy Dispersive X-ray were used to examine the surface morphology of copper samples. Quantum calculations and Monte Carlo simulation techniques were applied with informative yields and the results matched the experimental findings.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36167962 PMCID: PMC9515172 DOI: 10.1038/s41598-022-20306-4
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
List of pyrimidine derivatives utilized as corrosion inhibitors for various metals and alloys.
| Pyrimidine derivatives | Sample | Medium | %IE | References |
|---|---|---|---|---|
| a 2,6-dimethylpyrimidine-2-amine, | Mild steel | 0.5 M HCl | 96–97 at 10 mM | [ |
| a) 6‐methyl‐4‐morpholin‐4‐yl‐2‐oxo‐1,2,3,4‐tetrahydro‐pyrimidine‐5‐carboxylic acid ethyl ester | Carbon steel | 0.5 M HCl | 80–86 at 0,25 g/L | [ |
b) 6‐methyl‐4‐morpholin‐4‐yl‐2‐thioxo‐1,2,3,4‐tetrahydro‐pyrimidine‐5‐carboxylic acid ethyl ester c) 6‐methyl‐4‐morpholin‐4‐yl‐2‐oxo‐1,2,3,4‐tetrahydro‐pyrimidine‐5‐carboxylic acid hydrazide d) 6‐methyl‐4‐morpholin‐4‐yl‐2‐thioxo‐1,2,3,4‐tetrahydro‐pyrimidine‐5‐ carboxylic acid hydrazide | Mild steel | 0.5 M HCl | 80–86 at 0.25 g/L | [ |
| 5-Benzoyl-4-(4-carboxphenyl)-6-phenyl-1,2,3,4-tetrahydro-2-iminopyrimidine, 5-benzoyl-4-tolyl-6-phenyl-1,2,3,4-tetrahydro-2-thioxopyrimidine in 1 M HCl | Stainless steel | 1 M HCl | 90 at5 × 10-3 M | [ |
| 5-benzoyl-4-(substituted phenyl)-6-phenyl-3,4-dihydropyrimidine-2(1 | Stainless steel | 0.5 M H2SO4 | 92 at 2 × 10–3 M | [ |
a)5-(4-methoxyphenyl)-1,3,5,6,8-pentahydro-7-thioxo-pyrimido[4,5- b) 5-phenyl-1,3,5,6,8-pentahydro-7-thioxo-pyrimido[4,5-d] pyrimidine-2,4-dione, c) 5-(4-methoxyphenyl)-1,3,5,6,8-pentahydro-pyrimido[4,5-d] pyrimidine-2,4,7-trione d) 5-phenyl-1,3,5,6,8-pentahydro-pyrimido[4,5- | Mild steel | 1 M HCl | 97.1–88.0 at 400 ppm | [ |
| 1-(7-methyl-5-morpholin-4-yl-thiazolo[4,5-d] pyrimidin-2-yl)-hydrazine | Carbon steel | 0.5 M H2SO4 | [ | |
a) 4,6-diphenyl-3,4-dihydropyrimidine-2(1 b) 4-(4-methylphenyl)-6-phenyl-3,4-dihydropyrimidine-2(1 c) 4-(4-methoxy-phenyl)-6-phenyl-3,4-dihydropyrimidine-2(1 | Carbon steel | 1 M H2SO4 | 99–98 at 10 mM | [ |
a) 4-(4´-methylphenyl)-6-(phenyl)-3,4-dihydropyrimidine-2(1 b) 4-(4´-methoxylphenyl)-6-(phenyl)-3,4-dihydro-pyrimidine-2(1 | Stainless steel 304 | 2 M H2SO4 | 97.8, 96.2 at 5 mM | [ |
| (3a, MA-1230), (3b, MA-1231) and (3c, MA-1232) | Copper | 1 M HNO3 | 90.3–92.1 at 21 µM | [ |
(i) Ethyl(2-amino-5-methyl[1,4]-triazolo[1,5-a] pyrimidin-7-yl) acetate (ii) Ethyl (5-methyl[1,2,4] triazolo[1,5-a] pyrimidin-7-yl)-acetate | Mild steel | 1 | 84, 85, respectively at 10–3 M | [ |
| D-Glucose derivatives of dihydropyrido-[2,3-d:6,5-d0]-dipyrimidine-,4,6,8(1H,3H,5H,7H)- tetraone: GPH-3, GPH-2, GPH-1 | Mild steel | 1 | 93.9–97.8 at 10.15 × 10-5 M | [ |
| 3-(2-(4-(Hydroxymethyl)-1H-1,2,3-triazol-1-yl) ethyl)-2-methyl-6,7,8,9-tetra-hydropyrido [1,2-a] pyrimidin-4-one | Mild steel | 1 M HCl | 91 at 5 mM | [ |
| Losartan potassium (LP) drug | Q235 steel | 1 M HCl | 92.0 at 5 mM at 318 K | [ |
| 5-(Benzylthio)-1H-tetrazole (BTTA), 5-Benzyl-1H-Tetrazole (BTA) | Q235 steel | 0.5 M H2SO4 | 98.3% BTTA , 21.6% BTA for 2 mM | [ |
Figure 1The identified pyrimidinone derivatives' synthetic pathway MA-975 and MA-978C, reagents and conditions: (i) AcONa, H2O, DMSO, 5–10 °C; (ii) EtOH/AcOH, reflux.
Pyrimidine-bichalcophene derivatives' molecular structures, formulae, and weights.
| Inhibitor code | Molecular structures/ names | Mol. formulas (Mol. wt.) |
|---|---|---|
| MA-975 |
( | |
| MA-978C |
( |
Figure 2WL- time curves for dissolution of Cu alloy in 1 M HNO3 at different pyrimidine derivative concentrations (MA-978C and MA-975) at 25 °C.
k and %E of pyrimidine derivatives at various temperatures.
| Temp., oC | Conc, × 106 M | MA-978C | MA-975 | ||
|---|---|---|---|---|---|
| % | |||||
| 25 | Blank | 0.052 ± 0.0021 | – | 0.052 ± 0.0021 | – |
| 5 | 0.0179 ± 0.0015 | 65.6 | 0.0157 ± 0.0012 | 69.8 | |
| 9 | 0.0172 ± 0.0023 | 66.9 | 0.0125 ± 0.0014 | 76.0 | |
| 14 | 0.0156 ± 0.0026 | 70.0 | 0.0122 ± 0.0021 | 76.5 | |
| 17 | 0.0138 ± 0.0009 | 73.5 | 0.0116 ± 0.0020 | 77.7 | |
| 21 | 0.0088 ± 0.0019 | 83.1 | 0.0087 ± 0.0019 | 83.3 | |
| 30 | Blank | 0.089 ± 0.0022 | – | 0.089 ± 0.0022 | – |
| 5 | 0.0305 ± 0.0009 | 65.7 | 0.0211 ± 0.0017 | 76.3 | |
| 9 | 0.0242 ± 0.0023 | 72.8 | 0.0192 ± 0.0023 | 78.4 | |
| 14 | 0.0208 ± 0.0017 | 76.6 | 0.0179 ± 0.0020 | 79.9 | |
| 17 | 0.0178 ± 0.0026 | 80.0 | 0.0153 ± 0.0018 | 82.8 | |
| 21 | 0.0145 ± 0.0021 | 83.7 | 0.0136 ± 0.0021 | 84.7 | |
| 35 | Blank | 0.101 ± 0.0015 | – | 0.101 ± 0.0015 | – |
| 5 | 0.0318 ± 0.0017 | 68.5 | 0.0216 ± 0.0002 | 78.6 | |
| 9 | 0.0209 ± 0.0020 | 79.3 | 0.0202 ± 0.0023 | 80.0 | |
| 14 | 0.0181 ± 0.0021 | 82.1 | 0.0169 ± 0.0017 | 83.3 | |
| 17 | 0.0173 ± 0.0012 | 82.9 | 0.0108 ± 0.0018 | 89.3 | |
| 21 | 0.0161 ± 0.0017 | 84.1 | 0.0123 ± 0.0015 | 87.8 | |
| 40 | Blank | 0.137 ± 0.0020 | – | 0.137 ± 0.0020 | – |
| 5 | 0.0420 ± 0.0020 | 69.3 | 0.0274 ± 0.0017 | 80.0 | |
| 9 | 0.0276 ± 0.0023 | 79.9 | 0.0252 ± 0.0020 | 81.6 | |
| 14 | 0.0223 ± 0.0018 | 83.7 | 0.0205 ± 0.0018 | 85.0 | |
| 17 | 0.0209 ± 0.0026 | 84.7 | 0.0182 ± 0.0023 | 86.7 | |
| 21 | 0.0154 ± 0.0023 | 88.8 | 0.0151 ± 0.0020 | 89.0 | |
| 45 | Blank | 0.151 ± 0.0015 | – | 0.151 ± 0.0015 | – |
| 5 | 0.0379 ± 0.0023 | 74.9 | 0.0302 ± 0.0010 | 80.0 | |
| 9 | 0.0259 ± 0.0021 | 82.9 | 0.0257 ± 0.0015 | 83.0 | |
| 14 | 0.0227 ± 0.0013 | 85.0 | 0.0214 ± 0.0017 | 85.8 | |
| 17 | 0.0197 ± 0.0017 | 87.0 | 0.0194 ± 0.0020 | 87.2 | |
| 21 | 0.0164 ± 0.0018 | 89.1 | 0.0157 ± 0.0012 | 89.6 | |
Figure 3Arrhenius diagrams for Cu dissolution in the 1 M HNO3 solution of pyrimidine derivatives (MA-978C, MA-975).
Activation parameter for Cu dissolution in 1.0 M HNO3 in the absence and presence of (MA-978C and MA-975).
| Inhibitor | Conc., × 10–6 M | Activation parameters | ||
|---|---|---|---|---|
| − | ||||
| kJ mol−1 | kJ mol−1 | J mol-1 K-1 | ||
| Free Acid (1 M HNO3) | 68.71 ± 0.2028 | 88.29 ± 0.2403 | 175 ± 0.2504 | |
| MA-978C | 5 | 29.06 ± 0.2309 | 43.05 ± 0.1453 | 139 ± 0.2309 |
| 9 | 27.81 ± 0.1732 | 40.46 ± 0.2309 | 150 ± 0.2027 | |
| 13 | 26.96 ± 0.2333 | 37.37 ± 0.2729 | 161 ± 0.2603 | |
| 17 | 26.05 ± 0.2404 | 37.36 ± 0.1453 | 162 ± 0.1732 | |
| 21 | 25.19 ± 0.1453 | 36.24 ± 0.1453 | 167 ± 0.2333 | |
| MA-975 | 5 | 67.51 ± 0.2028 | 74.31 ± 0.1856 | 200 ± 0.2333 |
| 9 | 65.60 ± 0.1528 | 79.62 ± 0.1764 | 205 ± 0.2333 | |
| 13 | 64.92 ± 0.2603 | 76.69 ± 0.1528 | 211 ± 0.1856 | |
| 17 | 63.57 ± 0.2048 | 76.31 ± 0.1453 | 223 ± 0.1764 | |
| 21 | 62.68 ± 0.2028 | 61.89 ± 0.2646 | 224 ± 0.1453 | |
Figure 4Transition state diagrams for Cu dissolution in the 1 M HNO3 solution of pyrimidine derivatives (MA-978C, MA-975).
Parameters obtained from MA-978C, MA-975 adsorbed on the surface of the copper alloy in 1 M HNO3 acid at altered temperatures.
| Inhibitor | Temp °C | − Δ | Δ | Δ |
|---|---|---|---|---|
| MA-978C | 25 | 40.79 ± 0.2028 | 70.77 ± 0.1413 | 35.89 ± 0.2333 |
| 30 | 42.25 ± 0.1453 | 37.92 ± 0.2028 | ||
| 35 | 42.91 ± 0.1741 | 36.31 ± 0.1453 | ||
| 40 | 44.14 ± 0.1732 | 37.92 ± 0.1732 | ||
| 45 | 45.10 ± 0.2025 | 38.00 ± 0.2128 | ||
| MA-975 | 25 | 40.11 ± 0.1000 | 50.4 ± 0.1673 | 30.37 ± 0.1453 |
| 30 | 41.19 ± 0.1453 | 30.22 ± 0.1764 | ||
| 35 | 42.57 ± 0.1732 | 301.8 ± 0.1453 | ||
| 40 | 42.23 ± 0.1453 | 30.23 ± 0.1732 | ||
| 45 | 43.03 ± 0.1732 | 30.32 ± 0.2028 |
Figure 5Langmuir diagrams for Cu dissolution in the 1 M HNO3 solution of pyrimidine derivatives (MA-978C, MA-975).
Figure 6Nyquist bends for dissolution of copper metal in 1.0 M HNO3 attendance and nonattendance different concentrations of (a) MA-1978C, (b) MA-975 at 25 °C.
Figure 7Bode bends for dissolution of copper metal in 1.0 M HNO3 attendance and nonattendance different concentrations of (a) MA-978C (b) MA-975 at 25 °C.
Figure 8Equivalent circuit model for measuring EIS data.
Impedance parameters for copper alloy in 1 M HNO3 in presence and absence different concentrations of pyrimidine derivatives at 25 °C.
| Inh | Conc., µM | |||||||
|---|---|---|---|---|---|---|---|---|
| blank | – | 1.839 | 576.2 | 0.963 | 316.2 ± 0.2333 | 68.2 ± 0.1453 | – | 0.000087 |
| MA-978C | 5 | 1.914 | 451.7 | 0.972 | 205.7 ± 0.1453 | 113.7 ± 0.1764 | 40.1 | 0.000341 |
| 9 | 2.175 | 397.3 | 0.975 | 182.3 ± 0.1732 | 149.4 ± 0.2028 | 54.4 | 0.000653 | |
| 13 | 2.372 | 351.4 | 0.977 | 139.1 ± 0.1453 | 208.2 ± 0.2309 | 67.3 | 0.000453 | |
| 17 | 2.486 | 312.5 | 0.978 | 107.4 ± 0.2333 | 327.9 ± 0.1732 | 79.2 | 0.000654 | |
| 21 | 2.591 | 268.1 | 0.980 | 72.6 ± 0.1453 | 614.2 ± 0.1732 | 88.9 | 0.000745 | |
| MA-975 | 5 | 1.758 | 439.1 | 0.914 | 197.2 ± 0.1202 | 120.6 ± 0.2028 | 43.5 | 0.000065 |
| 9 | 1.831 | 392.4 | 0.969 | 174.6 ± 0.2309 | 156.1 ± 0.1732 | 56.3 | 0.000451 | |
| 13 | 1.905 | 345.2 | 0.982 | 132.5 ± 0.2028 | 213.9 ± 0.1453 | 68.1 | 0.000123 | |
| 17 | 1.938 | 306.3 | 0.985 | 98.1 ± 0.1732 | 374.2 ± 0.2028 | 81.8 | 0.000231 | |
| 21 | 2.106 | 262.5 | 0.987 | 67.3 ± 0.1553 | 685.8 ± 0.2309 | 90.1 | 0.000129 |
Figure 9EOC versus time at 25 °C for Cu in the acid corrosive medium in the absence and attendance dose of organic compound (21 × 10–6 M).
Figure 10PP bends for copper alloy in the 1 M HNO3 solution at altered dose of pyrimidine derivatives (a) MA-978C, (b) MA-975 at 25 °C.
PP measurements for copper alloy in 1 M HNO3 with and without altered concentrations of the tested pyrimidine derivatives at 25 °C.
| Conc, M × 106 | − | − | |||||
|---|---|---|---|---|---|---|---|
| Blank | −7± 0.1453 | 352.7 ± .1732 | 86.4 ± 0.2309 | 145.2 ± 0.2028 | |||
| MA-978C | 5 | 19.1 ± 0.2028 | 209.3 ± 0.2028 | 77.7 ± 0.2028 | 191.4 ± 0.1453 | 0.407 | 40.7 |
| 9 | − 29.2 ± 0.2431 | 168.1 ± 0.1155 | 85.4 ± 0.1732 | 157.50.2028 | 0.523 | 52.3 | |
| 13 | − 43.4 ± 0.2055 | 135.2 ± 0.2603 | 72.8 ± 0.2309 | 179.1 ± 0.2906 | 0.617 | 61.7 | |
| 17 | − 2.5 ± 0.1452 | 87.4 ± 0.1764 | 91.3 ± 0.2333 | 190.1 ± 0.1732 | 0.752 | 75.2 | |
| 21 | − 13.2 ± 0.1742 | 42.1 ± 0.2028 | 80.2 ± 0.1202 | 204.6 ± 0.2028 | 0.881 | 88.1 | |
| MA-975 | 5 | − 18.8 ± 0.2102 | 201.4 ± 0.1732 | 89.9 ± 0.1732 | 144.2 ± 0.17638 | 0.429 | 42.9 |
| 9 | − 1.1 ± 0.2209 | 158.1 ± 0.1453 | 137.6 ± 0.1453 | 148.6 ± 0.2082 | 0.552 | 55.2 | |
| 13 | 10.2 ± 0.2010 | 121.7 ± 0.1732 | 186.6 ± 0.2027 | 155.4 ± 0.1732 | 0.655 | 65.5 | |
| 17 | − 22.5 ± 0.1753 | 84.3 ± 0.2028 | 72.1 ± 0.2333 | 94.2 ± 0.2082 | 0.761 | 76.1 | |
| 21 | 19.1 ± 0.1208 | 35.7 ± 0.2010 | 124.1 ± 0.1764 | 139.9 ± 0.1764 | 0.899 | 89.9 | |
Figure 11SEM images of copper alloy without (blank) and with 21 µM of MA-978C, and MA-975 at 25 °C.
Figure 12EDX images of Cu alloy without (blank) and with 21 µM of MA-978C, and MA-975 at 25 °C.
The calculated quantum chemical parameters for the investigated pyrimidine compounds.
| Compound | MA-978C | MA-975 |
|---|---|---|
| − 9.43 | − 8.92 | |
| − 1.24 | − 1.01 | |
| 8.190 | 7.910 | |
| 9.43 | 8.92 | |
| 1.24 | 1.01 | |
| 4.095 | 3.955 | |
| 0.244 | 0.253 | |
| 5.335 | 4.965 | |
| Dipole moment (Debye) | 2.930 | 3.220 |
Figure 13Molecular structure of the pyrimidine compound, and its frontier molecular orbital density distribution (HOMO and LUMO).
Figure 14Equilibrium adsorption configurations of the inhibitors molecules on the Cu (111) surface: inhibitors side view and top view.
Equilibrium adsorption configurations of the inhibitors molecules on the Cu (111) surface.
| Structures | Adsorption energy | Rigid adsorption energy | Deformation energy | Compound dEad/dNi | H3O+ dEad/dNi | H2O dEad/dNi | |
|---|---|---|---|---|---|---|---|
| Neutral | Cu (111)/C23H25N5O6) | − 4095.203 | − 4027.378 | − 67.825 | − 272.939 | − 259.03 | − 11.271 |
| Cu (111)/C16H15ClN6O3) | − 4090.983 | − 4022.109 | − 68.874 | − 283.114 | − 261.79 | − 7.387 | |
| Protonated | Cu (111)/C23H25N5O6H+ | − 4163.765 | − 4083.24 | − 80.525 | − 281.869 | − 262.64 | − 12.361 |
| Cu (111)/C16H15ClN6O3H+) | − 4156.544 | − 4074.97 | − 81.574 | − 293.044 | − 265.28 | − 9.478 | |
Figure 15Mechanism of corrosion protection of Cu dipped in 1 M HNO3 media using MA-975, and MA-978C.